Positioning the new drugs for migraine

Expert Opin Drug Metab Toxicol. 2022 Jan;18(1):1-3. doi: 10.1080/17425255.2022.2049236. Epub 2022 Mar 9.

Authors

Silvia Benemei¹, Enrico Bentivegna^{2

3}, Paolo Martelletti^{2

3}

Affiliations

¹ Headache Centre and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy.
² Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
³ Regional Referral Hedache Center, Sant'Andrea University Hospital, Rome, Italy.

PMID: 35240909
DOI: 10.1080/17425255.2022.2049236

No abstract available

Keywords: CGRP(r) monoclonal antibodies; combination therapy; ditans; drug-drug interactions; gepants; migraine; precision medicine; safety.

Publication types

Editorial

MeSH terms

Calcitonin Gene-Related Peptide Receptor Antagonists*
Humans
Migraine Disorders* / drug therapy

Substances

Calcitonin Gene-Related Peptide Receptor Antagonists